EX-2.1 2 dex21.htm AGREEMENT AND PLAN OF MERGER AGREEMENT AND PLAN OF MERGER BY AND AMONG AMPIO PHARMACEUTICALS, INC., AMPIO ACQUISITION, INC., AND THE DMI BIOSCIENCES CONTROL SHAREHOLDERS DATED AS OF SEPTEMBER 4, 2010 AGREEMENT AND PLAN OF MERGERMerger Agreement • May 5th, 2020 • Colorado
Contract Type FiledMay 5th, 2020 JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of September 4, 2010, by and among DMI BioSciences, Inc., a Colorado corporation (the “Company”), Ampio Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Ampio Acquisition, Inc., a Colorado corporation and wholly-owned subsidiary of Parent (the “Merger Subsidiary”); and the Company’s Control Shareholders (as defined below). Each of the Company, Parent and Merger Subsidiary may be referred to herein as a “Party,” and collectively as the “Parties.”
AGREEMENT AND PLAN OF MERGER BY AND AMONG AMPIO PHARMACEUTICALS, INC., AMPIO ACQUISITION, INC., AND THE DMI BIOSCIENCES CONTROL SHAREHOLDERS DATED AS OF SEPTEMBER 4, 2010Merger Agreement • January 7th, 2011 • Ampio Pharmaceuticals, Inc. • Pharmaceutical preparations • Colorado
Contract Type FiledJanuary 7th, 2011 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of September 4, 2010, by and among DMI BioSciences, Inc., a Colorado corporation (the “Company”), Ampio Pharmaceuticals, Inc., a Delaware corporation (“Parent”), Ampio Acquisition, Inc., a Colorado corporation and wholly-owned subsidiary of Parent (the “Merger Subsidiary”); and the Company’s Control Shareholders (as defined below). Each of the Company, Parent and Merger Subsidiary may be referred to herein as a “Party,” and collectively as the “Parties.”
AGREEMENT AND PLAN OF MERGER BY AND AMONG CHAY ENTERPRISES, INC., AND CHAY ACQUISITIONS, INC. DATED AS OF MARCH 2, 2010Merger Agreement • March 8th, 2010 • Chay Enterprises, Inc. • Real estate • Colorado
Contract Type FiledMarch 8th, 2010 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of March 2, 2010, by and among DMI Life Sciences, Inc., a Delaware corporation (the “Company”), Chay Enterprises, Inc., a Colorado corporation (“Parent”), and Chay Acquisitions, Inc., a Delaware corporation and wholly-owned subsidiary of Parent (the “Merger Subsidiary”). Each of the Company, Parent and Merger Subsidiary may be referred to herein as a “Party,” and collectively as the “Parties.”